CA125-ANTIGEN LEVELS IN OBSTETRIC AND GYNECOLOGIC PATIENTS
- 1 January 1984
- journal article
- research article
- Vol. 64 (5) , 703-707
Abstract
An immunoradiometric assay using a monoclonal antibody detects an antigenic determinant (CA125) that is present in > 80% of epithelial ovarian cancers. CA125 levels are elevated in the sera of 16% of women in the 1st trimester of pregnancy and is found in very high concentration in amniotic fluid. In 988 nonpregnant patients with benign gynecologic disorders, CA125 was > 65 U/ml in 1% on a single determination and in 0.5% with 2 determinations. Given the low rate of positivity in benign gynecologic disease, the CA125 assay may deserve further evaluation for the early detection of ovarian carcinoma.This publication has 7 references indexed in Scilit:
- Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervixAmerican Journal of Obstetrics and Gynecology, 1984
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- Determinants of Ovarian Cancer Risk. I. Reproductive Experiences and Family History23JNCI Journal of the National Cancer Institute, 1983
- Immunopathologic Characterization of a Monoclonal Antibody that Recognizes Common Surface Antigens of Human Ovarian Tumors of Serous, Endometrioid, and Clear Cell TypesAmerican Journal of Clinical Pathology, 1983
- Reactivity of a monoclonal antibody with human ovarian carcinoma.Journal of Clinical Investigation, 1981
- AN EPIDEMIOLOGIC STUDY OF EPITHELIAL CARCINOMA OF THE OVARYAmerican Journal of Epidemiology, 1981
- Management of Ovarian CarcinomaNew England Journal of Medicine, 1976